Candriam Equities L Biotech.R EUR Acc H/  LU1708110975  /

Fonds
NAV8/12/2020 Chg.+2.1100 Type of yield Investment Focus Investment company
184.3700EUR +1.16% reinvestment Equity Worldwide Candriam Luxembourg 

Monthly performance

  Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec Total
2017 - - - - - - - - - - - 1.34 -
2018 6.48 -4.79 -2.32 -3.39 4.34 0.61 4.25 3.89 -2.24 -14.23 3.82 -8.57 -13.41%
2019 12.85 3.39 -0.87 -5.17 -4.67 9.21 -2.39 -2.50 -4.71 10.98 11.86 2.55 +31.84%
2020 -5.41 -1.57 -5.43 12.20 9.47 1.26 -2.99 -0.73 - - - - -

Calculated values

  YTD 6 Months 1 Year 3 Years 5 Years
Volatility 35.72% 38.87% 29.84% -% -%
Sharpe ratio 0.27 0.21 0.90 - -
Best month +12.20% +12.20% +12.20% +12.85% -
Worst month -5.43% -5.43% -5.43% -14.23% -
Maximum loss -25.36% -25.36% -25.40% - -
Outperformance -4.93% - +2.40% - -
 
All quotes in EUR

Tranches

Name   Type of yield Repurchase p. 1 Year 3 Years
Candriam Equities L Biotech.V US... reinvestment 1,727.9399 +29.22% +35.30%
Candriam Equities L Biotech.I EU... reinvestment 1,882.9700 +26.35% +25.07%
Candriam Equities L Biotech.R US... reinvestment 220.9500 +29.36% +35.73%
Candriam Equities L Biotech.R EU... reinvestment 184.3700 +26.37% -
Candriam Equities L Biotech.I US... reinvestment 4,751.7300 +29.19% +34.98%
Candriam Equities L Biotech.C EU... reinvestment 182.2500 +25.44% +21.91%
Candriam Equities L Biotech.C US... reinvestment 717.3800 +28.35% +32.61%
Candriam Equities L Biotech.C US... paying dividend 671.6700 +28.31% +32.49%

Performance

YTD  
+5.46%
6 Months  
+3.77%
1 Year  
+26.37%
3 Years     -
5 Years     -
Since start  
+23.69%
Year
2019  
+31.84%
2018
  -13.41%